Cargando…
Chronic Oral Selegiline Treatment Mitigates Age-Related Hearing Loss in BALB/c Mice
Age-related hearing loss (ARHL), a sensorineural hearing loss of multifactorial origin, increases its prevalence in aging societies. Besides hearing aids and cochlear implants, there is no FDA approved efficient pharmacotherapy to either cure or prevent ARHL. We hypothesized that selegiline, an anti...
Autores principales: | Szepesy, Judit, Humli, Viktória, Farkas, János, Miklya, Ildikó, Tímár, Júlia, Tábi, Tamás, Gáborján, Anita, Polony, Gábor, Szirmai, Ágnes, Tamás, László, Köles, László, Vizi, Elek Sylvester, Zelles, Tibor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999597/ https://www.ncbi.nlm.nih.gov/pubmed/33799684 http://dx.doi.org/10.3390/ijms22062853 |
Ejemplares similares
-
Anti-PD-1 Therapy Does Not Influence Hearing Ability in the Most Sensitive Frequency Range, but Mitigates Outer Hair Cell Loss in the Basal Cochlear Region
por: Szepesy, Judit, et al.
Publicado: (2020) -
Striking Neurochemical and Behavioral Differences in the Mode of Action of Selegiline and Rasagiline
por: Harsing, Laszlo G., et al.
Publicado: (2023) -
Hearing impairment and associated morphological changes in pituitary adenylate cyclase activating polypeptide (PACAP)-deficient mice
por: Fulop, Daniel Balazs, et al.
Publicado: (2019) -
Purinergic Signaling and Cochlear Injury-Targeting the Immune System?
por: Köles, László, et al.
Publicado: (2019) -
Selegiline: a molecule with innovative potential
por: Tábi, Tamás, et al.
Publicado: (2019)